Acute Glomerulonephritis Pediatric - Nursing Case Study

Pathophysiology

• Primary mechanism: Acute glomerulonephritis in children often follows infections, such as streptococcal throat infections. The body produces antibodies to fight the infection, but these can mistakenly target glomeruli, leading to inflammation and impaired kidney function.

• Secondary mechanism: The inflammation increases permeability of the glomerular capillaries, causing proteins and red blood cells to leak into the urine. This results in proteinuria and hematuria, common clinical manifestations.

• Key complication: Reduced glomerular filtration rate due to inflammation can lead to fluid retention, causing hypertension and edema. If untreated, prolonged kidney damage can progress to chronic kidney disease.

Patient Profile

Demographics:

8-year-old male, elementary school student

History:

• Key past medical history: Recent upper respiratory tract infection, history of mild eczema

• Current medications: None reported

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Swelling in the face and legs, decreased urine output

• Key symptoms: Hematuria, fatigue, headache, abdominal pain

• Vital signs: Blood pressure 140/95 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 37.8°C (100°F)

Section 1

As the clinical team conducts an initial assessment of the 8-year-old patient, several critical findings emerge that suggest a progression of his acute glomerulonephritis. Physical examination reveals significant periorbital and peripheral edema, consistent with fluid retention. Auscultation of the lungs indicates mild crackles at the bases, suggesting potential pulmonary congestion. The patient reports increased fatigue and a persistent headache, which may be indicative of worsening hypertension or fluid overload affecting cerebral circulation. Laboratory results further elucidate the situation: urinalysis shows marked hematuria and proteinuria, with urine output measured at only 0.5 mL/kg/hr, confirming oliguria. Serum creatinine is elevated at 1.2 mg/dL, indicating a decline in renal function, while hypoalbuminemia at 2.8 g/dL reflects significant protein loss.

Interpreting these findings, the healthcare team recognizes the necessity to address the complications aggressively. The high blood pressure, now at 145/98 mmHg, necessitates the initiation of antihypertensive therapy while ensuring fluid status is carefully monitored to prevent further overload. The presence of crackles and respiratory difficulty prompts the consideration of diuretics to alleviate pulmonary edema, though the team must weigh this against the risk of exacerbating renal impairment. The patient's recent history of an upper respiratory tract infection and current presentation of hematuria suggest possible post-streptococcal glomerulonephritis, warranting further serological tests, including antistreptolysin O (ASO) titers, to confirm the diagnosis and guide further treatment.

As the team deliberates these findings, they prepare to educate the family on the importance of monitoring blood pressure and urine output, emphasizing the need for regular follow-ups. They also discuss dietary modifications to manage edema and proteinuria, including sodium and protein restrictions. This comprehensive approach aims to stabilize the patient's condition and prevent the progression to chronic kidney disease, all while maintaining a vigilant eye for any new complications that may arise in this delicate pediatric case.

Section 2

As the clinical team continues to monitor the patient, a significant change in his status becomes evident. Over the next 24 hours, despite the initiation of antihypertensive therapy, the patient exhibits signs of increased respiratory distress. His respiratory rate has risen to 32 breaths per minute, and oxygen saturation has decreased to 92% on room air. Repeat auscultation reveals worsening crackles throughout both lung fields, suggesting an escalation of pulmonary congestion. The decision to administer a low-dose diuretic is made to address the fluid overload, but caution is exercised to avoid worsening renal function.

Further laboratory results arrive, providing new insights into the patient's condition. The antistreptolysin O (ASO) titer returns significantly elevated, reinforcing the suspicion of post-streptococcal glomerulonephritis. Additionally, a follow-up urinalysis shows persistent hematuria and proteinuria, while his serum albumin has decreased further to 2.5 g/dL. These findings confirm the continued nephrotic syndrome, and the hypoalbuminemia is contributing to his edema and pulmonary issues. A decision is made to adjust his dietary intake further, emphasizing low sodium and adequate caloric intake to support his energy needs, while carefully monitoring protein levels to manage his nephrotic state.

Recognizing the potential for further complications, the healthcare team strategizes to enhance their interventions. They consider the possibility of using angiotensin-converting enzyme (ACE) inhibitors to help reduce proteinuria and protect renal function, while closely monitoring blood pressure and renal parameters. The team also prepares to educate the family about recognizing signs of worsening respiratory distress and the importance of adhering to the new dietary plan. This proactive approach is crucial to stabilize the patient and prevent further deterioration, setting the stage for the next steps in managing his acute glomerulonephritis effectively.

Section 3

The decision to initiate a low-dose diuretic treatment appeared promising initially, as there was a slight improvement in the patient’s respiratory rate and oxygen saturation. However, over the next 12 hours, his condition began to change, raising concerns among the clinical team. The patient's blood pressure, which had been moderately controlled with antihypertensive therapy, began to drop unexpectedly. His blood pressure readings were now consistently recorded at 85/55 mmHg, indicating potential hypotension. Concurrently, lab results revealed a concerning increase in serum creatinine levels from 1.2 to 1.8 mg/dL, suggesting a decline in renal function.

In response to these developments, the healthcare team conducted a comprehensive reassessment of the patient's status. Physical examination confirmed the persistence of significant peripheral edema and a slight increase in jugular venous distention, suggesting ongoing fluid retention despite diuretic therapy. His heart rate had increased to 110 beats per minute, possibly compensating for the lower blood pressure. The team suspected that the diuretic, while attempting to alleviate pulmonary congestion, might have compromised the intravascular volume, leading to decreased renal perfusion and function.

Recognizing the delicate balance required to manage the patient's fluid status without further compromising renal function, the clinical team decided to adjust the diuretic dosage while closely monitoring the patient's hemodynamic status and renal function. They also considered temporarily pausing the ACE inhibitor therapy to prevent exacerbating the hypotensive state. The focus shifted to careful fluid management and supportive care, ensuring the patient remained hemodynamically stable while allowing time for renal function recovery. This strategic recalibration of treatment highlighted the need for vigilant monitoring and the delicate interplay between managing fluid overload and preserving renal function, setting the stage for the next phase of this complex case.

Section 4

As the clinical team reassessed the patient's response to the adjusted treatment plan, they noted a slight improvement in his blood pressure to 90/60 mmHg and a modest decrease in heart rate to 105 beats per minute. However, his serum creatinine level had continued to rise, now at 2.0 mg/dL, indicating ongoing renal impairment. Despite the reduced diuretic dose, peripheral edema persisted, and laboratory results showed hypoalbuminemia, with serum albumin levels falling to 2.8 g/dL. This indicated a potential nephrotic component to his glomerulonephritis, complicating fluid management further.

The team ordered a renal ultrasound to evaluate for potential structural changes or obstruction that might account for the deteriorating renal function. The imaging revealed slight enlargement of the kidneys with increased echogenicity, consistent with diffuse parenchymal disease, but no evidence of acute obstruction or hydronephrosis. These findings, combined with the laboratory data, suggested a worsening inflammatory process within the kidneys, necessitating a potential shift in the therapeutic approach.

With these new developments, the team contemplated introducing corticosteroids to address the inflammatory component of the condition, weighing the benefits against potential risks, including immunosuppression and further fluid retention. Meanwhile, they initiated albumin infusions to help mitigate the effects of hypoalbuminemia and support vascular volume. This decision required close monitoring to avoid exacerbating the patient's fluid overload. The evolving case underscored the need for a dynamic and integrated approach, balancing aggressive management of renal inflammation with careful fluid and hemodynamic stabilization, setting the stage for further complex decision-making in the patient's care journey.

Section 5

As the team proceeded with the corticosteroid treatment, they observed a temporary stabilization in the patient's condition. However, over the next 48 hours, the patient began exhibiting signs of worsening respiratory distress, characterized by increased work of breathing and decreased oxygen saturation levels, now at 88% on room air. Auscultation revealed bilateral crackles, suggesting pulmonary edema, likely exacerbated by the fluid retention effects of the corticosteroids and albumin infusion. This development prompted an urgent reassessment of the fluid management strategy, emphasizing the delicate balance between correcting hypoalbuminemia and avoiding fluid overload.

Concurrently, repeat laboratory investigations showed a further rise in serum creatinine to 2.5 mg/dL and a persistent decline in serum albumin, now at 2.6 g/dL, despite the albumin infusions. The team recognized that the inflammatory process within the kidneys was not yet adequately controlled, necessitating a reevaluation of the immunosuppressive regimen. They considered adjunctive therapies, including potential introduction of additional immunosuppressive agents or optimizing the corticosteroid dosage. Meanwhile, diuretic therapy was cautiously reintroduced at a low dose to alleviate the pulmonary congestion, with vigilant monitoring of renal function and electrolytes.

The patient's evolving condition highlighted the complexities of managing acute glomerulonephritis with nephrotic features, where fluid and inflammatory control must be meticulously balanced. The team prepared for further diagnostic interventions, such as a repeat renal biopsy, to better understand the underlying pathology and tailor the therapeutic approach. This case required dynamic clinical reasoning to adjust treatment plans swiftly in response to the patient's fluctuating status, underscoring the importance of an integrated, multidisciplinary approach in pediatric nephrology care.